Risk Factors Associated with Bacterial Vaginosis in Pregnant Women in Senegal
Microbiology Research Journal International,
Background: Bacterial vaginosis (BV) is associated with a high risk of complications, particularly during pregnancy.
Objectives: The aims of this study were to determine the prevalence of BV in pregnant women in Dakar, Senegal, and to identify its associated risk factors.
Patients and Methods: This prospective cross-sectional study was conducted from July 2020 to March 2021 in pregnant women with 34 to 38 weeks of gestation and seen for their routine prenatal consultation at the Nabil Choucair health center in Dakar, Senegal. Vaginal swabs were taken and examined using the Nugent scoring system for the diagnosis of the BV. Data analysis on SPSS (version 25) was done using the chi-square test to measure the strength of association. A value of p ≤ 0.05 was considered statistically significant.
Results: BV was found in 28.0% (112/400) of the screened women with a median age 24 (21-29) years. A pH >4.5 predictive of BV was found in 80.4% (90/112) of samples. BV was associated with vaginal candidiasis in 49.1% (55/112) while Trichomonas vaginitis was found in 1.8% (02/112). In 80.4% (90/112) of affected women, BV was caused by Gardnerella vaginalis. Mobiluncus spp. was found in 19.6% (22/112) pregnant women in association with G. vaginalis. Symptoms characterized by episodes of pruritus, pelvic pain, burning and/or dyspareunia were seen among 59.8% (67/112) of these women with BV while 40.1% (45/112) of them reported no symptoms.
Conclusion: In view of these results and in order to reduce gestational complications and adverse outcomes in the newborn, screening for BV in pregnant women should be favored in developing countries.
- Bacterial vaginosis
- pregnant women
- risk factors
How to Cite
Reiter S, Kellogg Spadt S. Bacterial vaginosis: an introduction for clinicians. Postgrad Med. 2019;131(1):8-18.
van de Wijgert JHHM, Jespers V. The impact of vaginal dysbiosis on global health. Res Microbiol. 2017;168(9-10):859-864.
Tolosa JE, Chaithongwongwatthana S, Daly S, et al. The International Infections in Pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears in pregnant women. Am J Obstet Gynecol. 2006;195(5):1198-1204.
Bautista CT, Wurapa E, Sateren WB, Morris S, Hollingsworth B, Sanchez JL. Bacterial vaginosis: review of the literature on the etiology, prevalence, risk factors and relationship with chlamydia and gonorrhea infections. Mil Med Res. 2016;3:4. Access on February 13, 2016.
Jespers V, Crucitti T, Menten J, et al. Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study. PLoS One. 2014;9(10):e109670. Access on 2014 Oct 7.
CDC. Bacterial Vaginosis - CDC Fact Sheet. Centers Dis Control Prev. 2017;5–6.
Ghattargi S, Sheela N, Dias M. Prevalence and risk factors for bacterial vaginosis in sexually active females in age group 20-45 years and comparison of Amsel's criteria with Nugent's score. Int J Reprod Contracept Obstet Gynecol. 2018; 7(9): 3478-3484.
Bitew A, Abebaw Y, Bekele D, Mihret A. Prevalence of bacterial vaginosis and associated risk factors among women complaining of genital tract infection. Int J Microbiol 2017;2017:4919404.
Desseauve D, Chantrel J, Fruchart A, et al. Prevalence and risk factors of bacterial vaginosis during the first trimester of pregnancy in a large French population study. Eur J Obstet Gynecol Reprod Biol. 2012; 163(1):30-34.
Liu L, Oza S, Hogan D, et al. Global, regional and national causes of under-5 mortality in 2000-2015: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet. 2016;388(10063):3027-3035.
Senegal2017_french1.pdf (healthynewbornnetwork.org) 17/11/2021
Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1-187.
Diadhiou M, Ba Diallo A, Barry MS, et al. Prevalence and risk factors for lower reproductive tract infections among symptomatic women in Dakar, Senegal. Infect Dis (Auckl). 2019;12: 1178633719851825.
Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Non-specific vaginitis. Diagnostic criteria and microbial and epidemiological associations. Am J Med. 1983;74(1):14-22.
Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297–301.
Tesfay Gebrehiwet, Deekonda Karthik, Paramasivam. Prevalence and associated risk factors of bacterial vaginosis among pregnant women in Africa: A systematic review; 2020.
Diagne R, Lo S, Dia ML, Ndour J, Ka R, Ngom B, et al. Genital Infections with Gardnerella vaginalis at Fann University Hospital (Dakar) and Saint-Louis (Senegal). Austin J Surg. 2019;6(12):1190.
Bonneton M, Huynh BT, Seck A, et al. Bacterial vaginosis and other infections in pregnant women in Senegal. BMC Infect Dis. 2021;21(1):1090. Published on 23 October 2021.
Shayo PA, Kihunrwa A, Massinde AN, et al. Prevalence of bacterial vaginosis and associated factors in pregnant women attending Bugando Medical Centre, Mwanza, Tanzania. Tanzan J Health Res. 2012;14(3):175-182.
Afolabi BB, Moses OE, Oduyebo OO. Bacterial and pregnancy-born vaginosis in Lagos, Nigeria. Open Infect Dis Forum. 2016;3(1):ofw030. Access on 2016 Feb 9.
Kamga YM, Ngunde JP, Akoachere JKT. Prevalence of bacterial vaginosis and associated risk factors in pregnant women receiving antenatal care in Kumba Health District (KHD), Cameroon. BMC Pregnancy Delivery. 2019;19(1):166. Access on 10 May 2019.
Mengistie Z, Woldeamanuel Y, Asrat D, Adera A. Prévalence de la vaginose bactérienne chez les femmes enceintes qui suivent des soins prénatals à l’hôpital universitaire Tikur Anbessa, Addis-Abeba, Éthiopie. Notes de BMC Res. 2014;7:822. Access on 2014 Nov 20.
Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard H, Olorunju SAS, Kock MM. A cross-sectional study on the relationship of age, gestational age and HIV infection to bacterial vaginosis and genital mycoplasma infection. BMJ Open. 2015;5:1–7.
Abdelaziz ZA, Ibrahim ME, Bilal NE, Hamid ME. Vaginal infections in pregnant women at Omdurman Maternity Hospital in Khartoum, Sudan. J Infect Dev Ctries. 2014;8(4):490-497. Access on 15 April 2014.
Awoniyi AO, Komolafe OI, Bifarin O, Olaniran O. Bacterial vaginosis among pregnant women attending a primary health care center in lle-Ife, Nigeria. Glo Adv Res J Med Med Sci. 2015;4:57–60.
Ibrahim SM, Bukar M, Galadima GB, Audu BM, Ibrahim HA. Prevalence of bacterial vaginosis among pregnant women in Maiduguri, Northeastern Nigeria. Niger J Clin Pract. 2014;17(2):154-158.
Achondou AE, Fumoloh FF, Aseneck AC, Awah AR, Utokoro AM. Prevalence of bacterial vaginosis among sexually active women attending the CDC central clinic tiko, South West Region, Cameroon. African J Infect Dis. 2016;10: 96–101.
Konadu DG, Owusu-Ofori A, Yidana Z, et al. Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana. BMC Pregnancy Delivery. 2019;19:341.
Aduloju OP, Akintayo AA, Aduloju T. Prevalence of bacterial vaginosis during pregnancy in tertiary health facility, southwestern Nigeria. Pan Afr Med J. 2019;33:9. Access on 7 May 2019.
Sobel JD, Ferris D, Schwebke J, et al. Suppressive antibacterial treatment with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis. Am J Obstet Gynecol. 2006;194(5):1283-1289.
Javed A, Parvaiz F, Manzoor S. Bacterial vaginosis: An overview of prevalence, alternative treatment regimen and its associated resistance patterns. Microb Pathog. 2019;127:21-30.
Jung HS, Ehlers MM, Lombaard H, Redelinghuys MJ, Kock MM. Etiology of bacterial vaginosis and polymicrobial biofilm formation. Crit Rev Microbiol. 2017;43(6):651-667.
Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 2000;342(8):534-540.
Abstract View: 52 times
PDF Download: 24 times